apixaban in cancer associated vte

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
apixaban in cancer associated vte	0.63	1	8798	81	33
apixaban	0.53	0.6	1098	92	8
in	1.69	1	9906	43	2
cancer	1.12	0.7	6814	67	6
associated	1.47	0.9	3866	21	10
vte	1.98	0.1	3816	68	3

Keyword	CPC	PCC	Volume	Score
apixaban cancer associated vte	1.2	0.6	5161	67
apixaban for vte prophylaxis	1.98	1	1272	24
apixaban in cancer patients	0.71	0.4	5167	78
apixaban in oncology patients	0.57	0.5	3358	17
apixaban dosing for vte	1.46	0.7	8418	49
apixaban vte prophylaxis dose	1.49	0.6	5009	43
apixaban use in thrombocytopenia	1.56	0.6	7160	89
risk of dvt on apixaban	1.87	0.3	4300	85
apixaban patient information leaflet dvt	0.89	0.4	6520	30
apixaban effect on platelets	1.86	0.7	9055	83
apixaban and platelet count	0.93	0.3	6633	41
dvt whilst on apixaban	1.2	0.4	4201	87
apixaban information for patients	2	0.9	5996	26
apixaban dvt patient leaflet	1.7	0.7	7486	39
apixaban for dvt prophylaxis	1	0.5	1021	26
does apixaban affect platelet count	1.56	0.3	7886	84
apixaban and blood tests	0.26	0.5	3506	3
risk assessment for apixaban	0.31	0.4	9492	47
apixaban 5mg patient information leaflet	0.85	0.8	7424	31
apixaban for renal vein thrombosis	0.55	0.7	8965	39
apixaban and bleeding risk	1.07	0.7	9855	73
apixaban for superficial vein thrombosis	1.08	0.5	5031	41
why would a patient be on apixaban	1.84	0.1	864	9